MedPath

ANM Adaptive Neuromodulation GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 4
1 (50.0%)

Acoustic Coordinated Reset (CR®) Neuromodulation for the Treatment of Chronic Tonal Tinnitus ("RESET Real Life")

Phase 4
Completed
Conditions
Tinnitus
First Posted Date
2011-09-16
Last Posted Date
2014-07-11
Lead Sponsor
ANM Adaptive Neuromodulation GmbH
Target Recruit Count
200
Registration Number
NCT01435317
Locations
🇩🇪

Dr. med. Mueller, Augsburg, Germany

🇩🇪

Dr. med. Jan Loehler, Bad Bramstedt, Germany

🇩🇪

Praxisverbund Berlin, Berlin, Germany

and more 20 locations

Clinical Investigation on the Acoustic Stimulation in the Treatment of Chronic Tinnitus

Phase 1
Completed
Conditions
Chronic Tonal Tinnitus
First Posted Date
2009-06-24
Last Posted Date
2012-04-19
Lead Sponsor
ANM Adaptive Neuromodulation GmbH
Target Recruit Count
63
Registration Number
NCT00927121
Locations
🇩🇪

Research Center Jülich // Institute for Neurosciences and Medicine - Research Center, Jülich, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.